Ascendis Pharma A-S
Price & Volume
Stats
See moreOpen | $233.19 |
Previous Close | $234.99 |
Day Range | $231.30-$235.56 |
52W Range | $124.06-$242 |
Market Cap | $14.4B |
Shares Short | 2M |
Financials
See moreRevenue (12 Mos) | $720.1M |
Revenue Growth (YoY) | 42.3% |
Gross Profit (12 Mos) | $625.2M |
Diluted EPS | -$4.44 |
News
See moreYahoo Finance • 3 days ago
Praxis Stock Surges 320% as One Biotech Investor's Buy Pushes Stake to Nearly $600 Million
Yahoo Finance • 3 days ago
Celcuity Stock Soars 700% in a Year as One Investor's $17 Million Buy Helps Create Top Two Position
Yahoo Finance • 3 days ago
Apogee Shares Up Nearly 100% in 12 Months, and This $62 Million Buy Signals Ongoing Conviction
Yahoo Finance • 5 days ago
Ascendis Pharma (ASND) Revenue Nearly Doubles to €720M in 2025 Fueled by Core Product Growth
About
CEO | Mr. Jan Moller Mikkelsen |
CFO | Mr. Scott T. Smith |
Address | Tuborg Boulevard 12, Hellerup, Denmark, 2900 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 1,189 |
